Carolyn Martin
Registered Nurse · Dallas, TXNPI 1447423108
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 200 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Among registered nurse clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 200 payments — averaging $20.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$622
- AstraZeneca$467
- AbbVie$406
- Amgen$387
- Pfizer$265
- Otsuka America Pharmaceutical, Inc.$232
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,150100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 34 | $622 |
| AstraZeneca | 20 | $467 |
| AbbVie | 27 | $406 |
| Amgen(2 entities) | 11 | $387 |
| Pfizer | 15 | $265 |
| Otsuka America Pharmaceutical, Inc. | 10 | $232 |
| Lilly USA, LLC | 12 | $213 |
| Boehringer Ingelheim | 9 | $196 |
| Astellas Pharma US Inc | 7 | $147 |
| Hologic Sales And Service, LLC | 3 | $116 |
| Biohaven Pharmaceuticals, Inc. | 4 | $112 |
| Sanofi | 1 | $112 |
| Merck | 6 | $111 |
| Currax Pharmaceuticals LLC | 6 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $86 |
| Abbott | 3 | $66 |
| Corcept Therapeutics | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Sanofi-aventis U.S. LLC | 3 | $48 |
| Alk-abello, Inc | 2 | $46 |
| GSK | 3 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $41 |
| Amarin Pharma, Inc. | 2 | $37 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| Kowa Pharmaceuticals America, Inc. | 2 | $33 |
| Genentech USA, Inc. | 3 | $32 |
| Dynavax Technologies Corporation | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Bayer | 1 | $20 |
| Organon | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,150 in reported general payments places this provider in the 95th percentile of 192 registered nurse providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 20 | $18,128 |
| MounjaroTirzepatide | 11 | $16,923 |
| JardianceEmpagliflozin | 12 | $12,036 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $9,523 |
| Repatha SureclickEvolocumab | 12 | $7,501 |
| EdarbiAzilsartan Medoxomil | 11 | $2,657 |
| SynthroidLevothyroxine Sodium | 21 | $1,911 |
| Valsartan | 24 | $608 |
| Atorvastatin Calcium | 50 | $440 |
| Alprazolam | 49 | $415 |
| Metoprolol Succinate | 20 | $407 |
| Rosuvastatin Calcium | 45 | $345 |
| Estradiol | 21 | $342 |
| Metformin Hcl | 29 | $327 |
| Omeprazole | 24 | $244 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $622 | $18,12820 claims |
| Lilly USA, LLCMounjaro | $213 | $16,92311 claims |
| Boehringer IngelheimJardiance | $196 | $12,03612 claims |
| AbbVieSynthroid | $406 | $1,91121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 192 registered nurse providers in Texas.
Other registered nurse in Dallas
- Steven LemoineDallas$1K
- Kimberly Arthur-MensahDallas$1K
- Brian VilayvanhDallas$331
- Carolyn SozaDallas$204
- Peter TanDallas$149
- Rebekah BuhlArlington$343K
- Lisa ReyesHouston$8K
- Katherine HowardAmarillo$7K
- Jennifer BruceFort Worth$7K
- Esther AnyaorahRichmond$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.